Monsanto (MON) Tops Q1 EPS by 7c; Guides to High-End of FY12 EPS Outlook
Tweet
Share
E-mailGet Alerts MON Hot Sheet
Price: $10.07 --0%
Financial Fact:
Research and development expenses: 387M
Today's EPS Names:
VAXX, EGRX, AFIB, More
Financial Fact:
Research and development expenses: 387M
Today's EPS Names:
VAXX, EGRX, AFIB, More
Join SI Premium – FREE
Monsanto Company (NYSE: MON) reported Q1 EPS of $0.23, $0.07 better than the analyst estimate of $0.16. Revenue for the quarter came in at $2.44 billion versus the consensus estimate of $2.04 billion.
The company guided to the high end of its full-year 2012 ongoing EPS mid-teens earnings growth guidance, expecting to achieve $3.39 to $3.44 of ongoing and as-reported EPS.
The company guided to the high end of its full-year 2012 ongoing EPS mid-teens earnings growth guidance, expecting to achieve $3.39 to $3.44 of ongoing and as-reported EPS.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- Nauticus Robotics (KITT) Reports Q2 Loss of $2.30
- Dynatrace to buy Arize in $915M cash-and-stock deal
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
